ÂÜÀòÂÒÂ×

The Directors Team at BryoLogyx is responsible for strategic decision-making, guiding the company's overall direction, and ensuring the successful development and implementation of cancer immunotherapies. This team comprises senior leaders and co-founders who oversee various facets of the company, from pharmaceutical development to research and development (R&D), ensuring that the company's innovative drug therapies meet regulatory and clinical standards.